Alexandros Makis: 20-year Cohort of 112 Children with Autoimmune Neutropenia
Alexandros Makis, Professor of Pediatrics/Pediatric Hematology at Faculty of Medicine, School of Health Sciences, University of Ioannina, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in British Journal of Haematology, adding:
“I am pleased to share our latest publication in the British Journal of Haematology.
In a 20-year cohort of 112 children with autoimmune neutropenia, we confirmed that it isn’t one condition — it’s three distinct phenotypes with very different paths: Primary autoimmune neutropenia — benign, resolving in nearly 19 months despite very low neutrophil counts.
Long-lasting neutropenia — strong familial autoimmunity, delayed resolution (nearly 67 months).
Late-onset neutropenia — multi-lineage lymphopenia, frequent ANA positivity and associated autoimmune disease, yet no severe infection-related hospitalisations.
A paradox explained by preserved humoral immunity.
These findings support phenotype-based stratification as a tool for improving clinical monitoring and management of childhood autoimmune neutropenia.
Grateful to my co-authors Ioanna Saougou, Chrysoula Kosmeri, Nikolaos Chaliasos, Irene Mavroudi and Charalampos Pontikoglou and to the families whose long-term follow-up made this work possible.”
Title: Phenotype-specific immune profiles and outcomes in childhood autoimmune neutropenia: A 20-year cohort study
Authors: Ioanna Saougou, Chrysoula Kosmeri, Nikolaos Chaliasos, Irene Mavroudi, Charalampos Pontikoglou, Alexandros Makis

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics